Nektar Therapeutics (NKTR) Gross Profit (2010 - 2025)
Nektar Therapeutics' Gross Profit came in at $21.81 million for Q4 2025, up 2.9% from $21.2 million a year earlier and up 85.0% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Gross Profit (2010 - 2025) Analysis & Trends
For FY2025, Nektar Therapeutics' Gross Profit was $55.23 million, down 18.5% from FY2024.
- Gross Profit carries a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- Going back by year, Gross Profit was $67.74 million in FY2024 (+20.2%), $56.35 million in FY2023 (-20.0%), $70.42 million in FY2022 (-8.6%) and $77.01 million in FY2021 (-42.3%).
- The Q4 2025 figure represents the highest quarterly Gross Profit since Q3 2020.
- Year-over-year, Gross Profit increased in four of the last eight quarters, with growth averaging 1.5%.
- The fastest year-over-year change in Gross Profit over five years came in Q3 2024 (growth of 68.1%), and the weakest in Q1 2021 (a decline of 61.7%).
- Business Quant data shows NKTR's Gross Profit at $11.79 million (Q3 2025), $11.18 million (Q2 2025) and $10.46 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 232.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 21.81 Mn |
| Sep 30, 2025 | 11.79 Mn |
| Jun 30, 2025 | 11.18 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Dec 31, 2024 | 21.20 Mn |
| Sep 30, 2024 | 19.69 Mn |
| Jun 30, 2024 | 13.75 Mn |
| Mar 31, 2024 | 13.11 Mn |
| Dec 31, 2023 | 16.60 Mn |
| Sep 30, 2023 | 11.71 Mn |
| Jun 30, 2023 | 13.51 Mn |
| Mar 31, 2023 | 14.53 Mn |
| Dec 31, 2022 | 15.79 Mn |
| Sep 30, 2022 | 18.65 Mn |
| Jun 30, 2022 | 16.47 Mn |
| Mar 31, 2022 | 19.51 Mn |
| Dec 31, 2021 | 18.85 Mn |
| Sep 30, 2021 | 19.61 Mn |
| Jun 30, 2021 | 20.66 Mn |
| Mar 31, 2021 | 17.89 Mn |
API Access
Nektar Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();